Aveanna Healthcare (NASDAQ:AVAH - Free Report) had its target price boosted by UBS Group from $3.20 to $4.50 in a report published on Friday,Benzinga reports. The firm currently has a sell rating on the stock.
Separately, Truist Financial decreased their target price on shares of Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating on the stock in a research report on Monday, January 6th.
Read Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Stock Performance
AVAH traded down $0.04 during trading on Friday, hitting $5.47. The stock had a trading volume of 488,033 shares, compared to its average volume of 234,561. Aveanna Healthcare has a twelve month low of $2.11 and a twelve month high of $6.19. The firm has a market capitalization of $1.06 billion, a P/E ratio of -16.09 and a beta of 2.25. The company's 50-day moving average price is $4.58 and its 200 day moving average price is $4.96.
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds and other institutional investors have recently modified their holdings of the company. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare in the fourth quarter worth about $35,000. BNP Paribas Financial Markets bought a new stake in Aveanna Healthcare in the fourth quarter worth about $35,000. Tower Research Capital LLC TRC raised its position in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after acquiring an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd raised its position in Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after acquiring an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC bought a new stake in Aveanna Healthcare in the fourth quarter worth about $57,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
